Johnson & Johnson (NYSE:JNJ) recently experienced a 12% price increase over the last quarter, largely driven by significant ...

RedHill Biopharma (RDHL) announced plans to advance its groundbreaking late-stage program for Crohn’s disease, or CD, with initiation of an ...

HOUSE, PA — Johnson & Johnson (NYSE: JNJ) announced promising topline data from its Phase 2b ANTHEM-UC clinical trial evaluating icotrokinra (JNJ-2113) as a treatment for moderately to severely active ...

Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis.

Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts ...

Results from multiple Phase III trials of Icotrokinra in moderate-to-severe plaque psoriasis and a Phase IIb trial in ...

Drinking two small glasses of cherry juice daily may help reduce gut inflammation and improve the quality of life for people ...

Icotrokinra met all primary endpoints in the studies, demonstrating significant skin clearance and clinical remission.

A CT scan confirmed Phoebe had suffered a stroke and she spent four days being tube-fed and bedridden. Tests later revealed ...

The following information was submitted by Intermountain Health.Colorectal cancer is the second most common cancer and the ...